XML 67 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net loss $ (17,418,151) $ (4,371,491)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property and equipment 19,341 7,990
Amortization of platform development and intangible assets 1,418,223 226,000
Amortization of debt discounts 373,663
Change in valuation of derivative liabilities 263,531 6,939
True-up termination fee 1,344,648
Settlement of promissory notes receivable 1,166,556
Loss on extinguishment of debt and accrued interest 1,099,165
Liquidating damages payable 2,667,798
Stock based compensation 3,416,110 1,357,510
Deferred income taxes (91,633)
Change in operating assets and liabilities net of effect of business combinations:    
Accounts receivable, net (491,644) (3,482)
Prepayments and other current assets (101,603) 19,322
Deferred contract fulfillment costs (5,191) (15,986)
Accounts payable 467,083 (102,793)
Accrued expenses 81,689 203,271
Contract liability 11,537 31,634
Deferred rent 17,245
Net cash used in operating activities (6,288,695) (2,654,964)
Cash flows from investing activities    
Purchases of property and equipment (29,259) (43,043)
Payments of promissory notes receivable (3,695,054)
Capitalized platform development (1,660,331) (1,470,770)
Payments for acquisition of business, net of cash (9,032,596)
Net cash used in investing activities (14,417,240) (1,513,813)
Cash flows from financing activities    
Proceeds from issuance of Series H convertible preferred stock 12,474,704
Proceeds from 8% promissory notes 1,000,000
Payment of 8% promissory notes (1,351,334)
Proceeds from 10% convertible debentures 4,775,000
Proceeds from common stock to be issued in private placement 1,750,000
Proceeds from private placement of common stock 1,250,000 3,519,544
Payment of issuance costs of Series H convertible preferred stock (159,208)
Proceeds from officer promissory notes 1,009,447
Repayment of officer promissory notes (49,911)
Net cash provided by financing activities 18,948,698 5,269,544
Net (decrease) increase in cash, cash equivalents, and restricted cash (1,757,237) 1,100,767
Cash, cash equivalents, and restricted cash - beginning of period 3,619,249 598,294
Cash, cash equivalents, and restricted cash - end of period 1,862,012 1,699,061
Supplemental disclosure of cash flow information    
Cash paid for interest 23,575
Cash paid for income taxes
Noncash investing and financing activities    
Reclassification of stock based compensation to platform development 1,508,889 688,302
Discount on 8% promissory notes credited to derivative liability 760,499
Discount on 10% convertible debentures credited to derivative liability 471,002
Aggregate exercise price of common stock options exercised on cashless basis 21,250
Aggregate exercise price of common stock warrants exercised on cashless basis 168,423
Accrual of stock issuance costs 184,000
Reclassification of investor demand payable to stockholders' equity 3,000,000
Fair value of common stock issued for private placement fees 150,000
Common stock issued for investment banking fees 200,880
Deemed dividend on Series H convertible preferred stock 18,045,496
Assumption of liabilities in business combination 851,114
Issuance of Series H convertible preferred stock for private placement fee $ 669,250